Literature DB >> 2372593

Enalapril and metoprolol in diabetic nephropathy.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2372593      PMCID： PMC1662956          DOI： 10.1136/bmj.300.6736.1399

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  P T Sawicki; I Mühlhauser; T Baba; M Berger
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

2.  Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

Authors:  W H Inman; N S Rawson; L V Wilton; G L Pearce; C J Speirs
Journal:  BMJ       Date:  1988-10-01

3.  Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.

Authors:  C J Speirs; C T Dollery; W H Inman; N S Rawson; L V Wilton
Journal:  BMJ       Date:  1988-10-01

4.  Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nyberg; M Aurell
Journal:  BMJ       Date:  1990-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.